Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Beckman Coulter
Beckman Coulter licenses Roche's real time PCR patent portfolio
August 18th, 2006
Beckman Coulter, Inc., (BEC) announced that the company has acquired an in vitro diagnostics product license to all real time polymerase chain reaction (PCR) patents and pending patent applications owned or controlled by Roche Diagnostics, a division of F. Hoffmann-La Roche Ltd, Basel, Switzerland. Beckman Coulter will pay Roche a one time license fee of $27.5 million and will also pay royalties on sales of all licensed products. "Real time PCR is the most widely accepted technology for the quantitative amplification and detection in molecular testing," said Scott Garrett, CEO. "We recently announced that Beckman Coulter reached a settlement with...
Source: Biotech Law Weekly (2006-08-18)
|
